Shitong Xie

Valuation of SF-6Dv2 Health States in China Using Time Trade-off and Discrete-Choice Experiment with a Duration Dimension

Jing Wu, Shitong Xie, Xiaoning He et al. · PharmacoEconomics · 2021 · 83 citations · Full text

Pharmacy, Psychology, Health Assessment +16

Population Norms for SF-6Dv2 and EQ-5D-5L in China

Shitong Xie, Jing Wu, Feng Xie · Applied Health Economics and Health Policy · 2022 · 54 citations

Public Health, Health Sciences, Population Health Sciences +9

Comparison of the measurement properties of SF-6Dv2 and EQ-5D-5L in a Chinese population health survey

Shitong Xie, Dingyao Wang, Jing Wu et al. · Health and Quality of Life Outcomes · 2022 · 51 citations · Full text

Pharmacy, Health Sciences, Population Health Sciences +17

Canada population norms for the EQ-5D-5L

Jiajun Yan, Shitong Xie, Jeffrey Johnson et al. · The European Journal of Health Economics · 2023 · 42 citations

Public Health, Health Sciences, Population Health Sciences +5

Do Discrete Choice Experiments Approaches Perform Better Than Time Trade-Off in Eliciting Health State Utilities? Evidence From SF-6Dv2 in China

Shitong Xie, Jing Wu, Xiaoning He et al. · Value in Health · 2020 · 36 citations · Full text

Pharmacy, Decision Sciences, Economics +12